DeSmog

DeSmog reports that pharmaceutical companies lobbied to weaken the rules governing the United Nations' biodiversity fund, the Global Environment Facility. The investigation suggests industry sought to dilute accountability safeguards and influence how nature funds are governed. Environmental advocates are sharing the findings as fresh evidence of corporate lobbying targeting UN climate and biodiversity institutions.